Given the paucity of evidence that guides treatment recommendations for patients with CP-B liver function diagnosed with HCC, it is important to expand the current pool of data and further delineate class CP-B liver function into its constituents. The gene discussed is CPB1; the disease is hepatocellular carcinoma.